chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After given 2 hepatitis vaccines, within 1 minute, pt said 'oh no' and placed his head on table, then back on head of chair. He seemed to 'fall asleep', with snoring. He then started tensing up his arms, we laid him flat on the floor and supported his head. We kept calm and kept saying 'it's ok' and rubbing his hands. Tensed arms, straight and then to his side. Made a strained face and sound while tensing arms.  Got an ice pack to place on his head, to try to bring him about. Finally did 'wake up' within a couple minutes. He first asked 'where am I'. We all said at work. He seemed fine, while still laying, he knew he had received shots and felt nervous about them, he knew his friend who was in the room and that he was there. He felt embarressed, but said he bite his tongue and neck was a little sore. Pt thinks he 'blacked out', said he had this happen during an accident where he cut himself and also when he had his lip pierced. As a medical professional, this appeared to look like a seizure. His tensed body, mainly arms, snoring, clenched jaw. Very strange. Pt has no history of seizures, although they seem to run in his family. He has not had any vaccines as an adult. I advised him to get a family doctor and to get checked out. Advised him to not get any vaccines until check out by md. Md may call our pharmacy for details on this reaction.
At 12:00am on the 20th I began to have chills. I felt very cold and couldn't warm up despite having multiple blankets. I was very fatigued and felt "out of myself". I awoke around 4am with a terrible headache and sweats. I took Advil and  laid back down. The headache subsided when I awoke again at 8am but the fever seemed apparent still as I was still sweating. As the day went on around 12pm I began to have severe joint pain in my shoulders, back, hips, and arms that didn't subside until around 6-8pm. I was also very lethargic and fatigued. I slept through the night and awaking on the 21st the aches had gone. I had a very slight fever, minor fatigue, and still didn't feel like myself, or "checked-in". By the 3rd day on the 22nd, I was fine, but exhausted.
On 6/27/22, felt dizzy around 8:30 am and had to hold on to a counter not to fall. Then also felt nauseous all day until 9:30 pm when I took Drammamine. Today is 6/29/22 and the dizziness came back and took Drammamine again at 12:30 pm. But this time, I still feel dizzy at 5:30 pm. Listed are all the COVID vaccines I received on 2/28/21, 3/28/21, 4/11/21, and 5/10/22
Info has been received from a health professional concerning an 8 year old white female with allergies to penicillin and sulfonamide who's mother called the office and said that her daughter was vaccinated with a dose of varicella virus vaccine live and had disease in the past. It was noted that the pt had strep pharyngitis and broke out with a rash at the time of vaccination. This day on 3/31/05 at 10:02 AM, the pt had 9 lesions and fever. Medical attention was not sought. Follow-up info from a health professional indicated that the pt's mother stated that, on 3/31/05, the child had a total of 45 lesions with no scars. There were new lesions for 5 days. It was reported that the pt had a scarlet fever rash and strep throat at the same time. The pt is now doing fine with no lasting problems from the disease. The pt was reported as recovered on 4/5/05. Additional info is not expected.
PATIENT STATED SHE BECAME EXTREMELY EXHAUSTED; RAN A LOW-GRADE FEVER OF 100.5; AND HAD A HEADACHE.
This spontaneous report as received from medical assistant refers to a patient of unknown age who in May 2012 was vaccinated with the first dose of GARDASIL and the second dose of GARDASIL on an unspecified date in her pediatrician's office. The second dose was given "late" but the date was unknown. The patient was in the office "today" on 25-OCT-2012 to receive the third dose of GARDASIL. No adverse effects reported. The outcome for the event was unknown. Additional information has been requested.
patient came in 12/9/21 and told me that she got bruisitis from the injection. patient is a nurse. she is seeing PT. may need steroid injection. cannot lift arm.
Within an hour of receiving 2nd dose started experiencing headaches and dizziness. In addition to the headaches and severe dizziness I started having significant bouts with diarrhea, malaise, loss of appetite and have not slept well.  Within a couple days I noticed pronounced tremors in my right hand and I started losing weight from 180 pounds to 157, around 23 pound loss.  I contacted my physician and was alerted to make this report and have an appointment on March 1.
Hot arm immediately after and soreness Itching started  Jan 16th noticed swelling , redness and hot to the touch on injection site today jan 20th 8 a.m.
Patient described having a "mild reaction" to first dose Pfizer BioNTech vaccine, and pre-mediated with 50 mg diphenhydramine as well as her morning cetirizine 10 mg before the second dose. Approximately 10 minutes s/p second dose the patient experienced dizziness, facial tingling, anxiety, hard and soft palate numbness, and flushing. She was helped to a stretcher and her BP was 204/94. The patient was taken to the ED for further monitoring.  In the ED, she denied any throat swelling, tongue swelling, or difficulty breathing on arrival. She also denied any chest pain and palpitations. She received methylprednisolone 125 mg IV x 1 and a liter of normal saline, underwent observation, then discharged home uneventfully.
pain lt femur & low back; fever to 102, sed rate inc 50; WBC 24,000 w/dramatic lt shift; began 16 hrs p/vax;
no adverse effect; multiple patients were vaccinated with improperly stored VAQTA on multiple dates; This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 12-FEB-2019, the patient was vaccinated with improperly stored hepatitis a vaccine, inactivated(VAQTA) lot # R010369, expiry date 25-MAR-2019 for prophylaxis.  No adverse event was reported. Previous temperature excursion was reported. Data logger was involved.
Mom called and reported headache, dizziness, and numbness/tingling in hands and feet.
Pt presented with rash 1/30/08 approximately 15 pustules. Rash started 1/28/08.
felt sick tired and no appetite, and headache the day after the vaccine the next day felt ok no complaints still no real appetite the third day had coffee got up to do dishes and apparently just dropped where she stood and died.
Day of vaccine- headache, dizziness, mild nausea  Day 2- headache, body aches Day 3-present- headaches mild
Within 30-45 minutes of the booster I began having abdominal cramps and felt the onset of diarrhea. Within an hour, I had to rush home from work because of intense diarrhea. After it passed from my system, I took an Imodium and did not have further problems.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date in (also reported as "on 21-SEP-2016"), the patient was vaccinated an improperly stored dose of VARIVAX injection, lot # K016132, expiry date 21-SEP-2016 (dose, route of administration an anatomical location were not specified). No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
father states symptoms started at 10 PM on 2/2/09 he was trembling, and muscle twitching. then about 5:30 AM on 2/3/09 woke up sick, dizzy, got up and walked and fell over, upper and lower extremities twitching lasting about 30 seconds. presneted to clinic around 8:45 AM 2/3/09 feeling weak and tachycardic, Pulse 135-140. Evaluated by Nurse NP who conferred with MD and decided to send to ER for further evaluation.  2/9/09 Received ER medical records of 2/3/2009. FINAL DX: black out & seizure Records reveal patient experienced seizure x approx 30 secs that AM.  Exam WNL.    2/11/09 Received PCP vaccine records & clinic medical records of 2/3/2009. FINAL DX:none provided Records reveal patient experienced trembling, feeling hot & cold all night & then had witness seizure in AM.  Continued to feel anxious & lightheaded on exam with increased heart rate & BP.  Sent to ER for eval.
Patient received First dose of modenra Bivalent vaccine; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received First dose of modenra Bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in an infant patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Patient received First dose of modenra Bivalent vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received First dose of modenra Bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient received First dose of modenra Bivalent vaccine).    No concomitant medication was reported.  No treatment information was reported.
PATIENT REPORST DEVELOPING SOREES IN MOUTH 3 DAYS AFTER, REMAINED FOR ONE WEEK.  rETURNED AGAIN IN 10-12 DAYS.  REPORTS CHANGE IN PIGMENTATION OF TONGUE.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 17Nov2022 as dose 5 (booster), single (Lot number: GL0446), in left arm and on 09Jul2023 as dose 6 (booster), single (Lot number: GL2042) at the age of 70 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Suspected glaucoma (current)" (unspecified if ongoing); "Inactive ulcerative colitis" (unspecified if ongoing); "Age-related enlarged prostate" (unspecified if ongoing); "Low blood pressure" (unspecified if ongoing); "Known allergies: No" (unspecified if ongoing). Concomitant medication(s) included: CALCIUM SUPPLEMENT WITH VITAMIN D, start date: Jan2003, stop date: 27Aug2023; FLAXSEED OIL, start date: Jan2003, stop date: 27Aug2023; ASACOL, start date: Jan2003; INFLAVONOID INTENSIVE CARE, start date: Jan2013, stop date: 27Aug2023; PROBIOTIC COMPLEX, start date: Jan2018, stop date: 27Aug2023; CRANBERRY, start date: Jan2022, stop date: 27Aug2023; ALFUZOSIN, start date: Jul2022, stop date: 27Aug2023; SAW PALMETTO BERRY, start date: 01Jul2023, stop date: 27Aug2023. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient received Paxlovid treatment from 27Aug2023 to 01Sep2023. Patient also received concomitant medications: Travaprost with start date Jan2015 and Multivitamin with start date Jan2003 and stop date 27Aug2023.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300293493 Same reporter/patient, different drug/event.;
Arthralgia, Fever, Diarrhea, chills & fatigue Pt reported Chills, fever , diarrhea, arthralgia, fatigue on same day after covid vaccination dose #2. Symptoms resolved after pt took tylenol for treatment.
Information has been received from a 71 year old male patient with "CT dyes" allergy hay fever and gastroparesis who in 1999 was vaccinated with a first dose of PNEUMOVAX 23 (Lot# not reported), in 2004 was vaccinated with a second dose of PNEUMOVAX 23 (Lot# not reported) (unknown if consumer had previous problems with prior vaccinations). On 19-OCT-2010, the patient was vaccinated with a third dose of PNEUMOVAX 23 (Lot# 665925/0932Z). Concomitant therapy included ACIPHEX, montelukast sodium (MSD), ezetimibe (MSD) and NORVASC. The patient stated that on 19-OCT-2010, he experienced chills and his "fingers burned". On 20-OCT-2010 his left arm became red and felt like it was "burning". The patient saw the physician on 21-OCT-2011 and was given "a shot of steroids, and was given a prescription for KEFLEX antibiotic for 5 days". The consumer stated that after five days on KEFLEX his arm "went from red to orange to yellow to somewhat normal". On approximately 30-OCT-2010 the patient developed pimple under the arm and put NEOSPORIN on the pimple and the pimple went away 3-4 days later. It was also reported that on approximately 24-NOV-2010 the patient developed a new growth in my left armpit. The new growth had started as a pimple and it got white with puss, he also went to the doctor for his neck pain and tightness in his left arm and shoulder which was emulating to his neck; his physician put him on BACTRIM for the growth in his armpit, the patient mentioned that this growth was healing, but still had a small area of redness and on 05-DEC-2010 he developed two new "growths" in his left armpit, one was about an inch long and the other was 1/2 inch long", the growths were described as red raised areas without any drainage, which were present at the time of the report. On unspecified date on X-RAY was performed (no results provided). The patient stated that "all my symptoms are related to the PNEUMOVAX 23." The patient reported he has not recovered. Additional information has been requested.
Hospitalized 12/5/2021; COVID-19 positive 12/5/2021; fully vaccinated  BRIEF OVERVIEW:   Admission Date: 12/5/2021 Discharge Date: 12/8/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia  Pneumonia due to COVID-19 virus    HOSPITAL COURSE BY PROBLEM:   * Pneumonia due to COVID-19 virus Assessment & Plan Patient is a 59-year-old female with a history of AFib on Xarelto, OSA on BiPAP, hypertension, morbid obesity, diastolic congestive heart failure, chronic obstructive pulmonary disease, bariatric surgery, presenting to our institution with cough and fatigue.  She had associated nausea, poor appetite and vomiting, she also reported diarrhea.  Symptom onset is approximately 1 week before presentation though she was having cold-like symptoms around Thanksgiving.  In the emergency department she was found to be mildly hypoxic with O2 saturations 89%.  She tested positive for COVID-19, the patient had been vaccinated but had not had booster.  Chest x-ray concerning for bilateral infiltrates.  She was admitted to the general medicine service for management of COVID-19 pneumonia.   She was started on dexamethasone 6 mg daily as well as remdesivir.  Patient rapidly weaned off of supplemental oxygen, remaining on room air at rest and with activity.  In regards to her chronic obstructive pulmonary disease she likely had a mild exacerbation with good response to bronchodilator therapy and dexamethasone 6 mg daily.  Her CRP was trended, improving from 77 to 29.3.  Procalcitonin was negative.  NT proBNP was normal.  Doppler ultrasound of the lower extremities revealed no evidence of DVT, though she does have a left-sided popliteal cyst.   Symptoms improved, she worked with physical therapy and occupational therapy and was felt to be safe for home with assist.  She is weaned off of oxygen.  Will continue dexamethasone 6 mg daily to complete a 10 day course.  Is advised to return to the hospital she has any worsening symptoms or swelling in the lower extremities.  She is advised to pursue a COVID-19 booster when she recovers from her COVID-19 illness and is out of isolation, she should also receive an influenza vaccination and be considered for Prevnar 13. She will discuss this with her primary care physician
Body Aches, onset: 4/17/2021  Body Aches, continues 4/18/2021 Fever Onset: 4/18/2021 Fever (back to normal) 4/19/2021
1 of 3 pts who exp a knot @ the inject site (2x4 cm) following immun w/DTP; all 3 pts were immunized from the same vial;
Fever after 24 hours; muscle aches; head ache; dizziness; general malaise/fatigue; red and swollen arm at injection site 48 hours after; lingering headache, dizziness and muscle aches after 72 hours.
Increased fatigue, increased temperature, joint and muscle pain and swekking for 24 hours.
Eat extra salty foods and stop high blood pressure medication (labetalol 100 mg).
Papular urticaria: weals, itchy papules and exaggerated inflammation to aedes mosquito bites. Break out of additional hives after insect bite. Patient has no prior history of hives or papular urticaria.
No additional AE reported; nurse calling to report a temperature excursion for PNEUMOVAX 23; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided.      On 28-FEB-2022, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot number U026796, expiration date 28-JAN-2023 (dose and route of administration not reported) as prophylaxis, underwent a temperature excursion of 48.8 Fahrenheit for 96 hours. No adverse event was reported.  No previous temperature excursions were reported.  This is one of 4 cases received from the same reporter. ; Sender's Comments:  US-009507513-2203USA002142: US-009507513-2203USA000257: US-009507513-2203USA002144:
She has been throwing up; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (primary immunization series complete;  unknown manufacturer), for Covid-19 immunization. The following information was reported: VOMITING (non-serious), outcome "unknown", described as "She has been throwing up".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
No adverse reaction, Pt had full blown case of chicken pox.  > than 100 lesions. 12/27/99 - 1/3/00.
Information was received from a consumer about her daughter who in 1997 was vaccinated with a dose of VARIVAX (Merck) (lot not reported). It was reported that the patient was diagnosed with diabetes two days after receiving the VARIVAX (Merck). The mother asked about reimbursement of medical expenses as a result of reaction to vaccines. The patient was reported as not recovered from the event. No additional information was provided. Additional information has been requested.
approx. 28 hours after the shot, the arm where the injection was placed began to hurt inside the armpit and in lymph nodes of left arm. The area in and around my armpit became swollen and has remained painful and swollen 3 days later
16-year-old patient came into pharmacy for a booster dose (third dose) of COVID-19 Pfizer vaccine. After RPh gave vaccine. She discovered the adult dose (0.3mL) of pediatric vaccine had been given. RPh contacted parent to inform about dosage given and advised parent to follow-up with pediatrician to see what next step may look like. Parent grateful for the call and understood the situation.
Hives (all over legs, top to bottom; top of hands; arms) and leg/joint (knee) pain that started a few days after shot. Treated with BENADRYL but would come back as BENADRYL wore off. Lasted for 3-4 days.
This is a spontaneous report from a contactable consumer, the patient. A forty-two-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Apr2021 at 10:00 (at the age of forty-two-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any concomitant medications. The patient was allergic to anti diarrheal medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the patient experienced armpit hurts and sometimes her muscle by clavicle hurts a little. The adverse event did not result in a visit to the doctors or other Healthcare Professional office/Clinic visit, and Emergency Room/Department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events armpit pain and muscle pain was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This case was reported by a healthcare professional and described the occurrence of influenza-like symptoms in an 86-year-old female subject who was vaccinated with Flulaval (GlaxoSmithKline).  In September 2007 the subject received the first dose of Flulaval (.5 ml, unknown, unknown arm).  At an unspecified time after vaccination with Flulaval, the subject experienced influenza-like symptoms and cough.  At the time of reporting the events were unresolved.
Has not received a 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Has not received a 2nd dose) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not received a 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Has not received a 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  As on 27-Jul-2021, patient has not yet received the second dose of mRNA-1273 (Moderna COVID-19 Vaccine) and was looking forward to get the second dose on the upcoming Friday (30-Jul-2021).   This case was linked to MOD-2021-252740 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Follow-up document was received. Reporter's email was added. It contains non significant information.